X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (118) 118
child (84) 84
index medicus (84) 84
oncology (84) 84
female (81) 81
male (80) 80
infant (79) 79
child, preschool (77) 77
adolescent (61) 61
neuroblastoma (57) 57
pediatrics (46) 46
cancer (44) 44
children (40) 40
chemotherapy (35) 35
prognosis (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
hematology (30) 30
tumors (28) 28
treatment outcome (26) 26
neuroblastoma - pathology (24) 24
adult (22) 22
follow-up studies (22) 22
infant, newborn (22) 22
risk factors (22) 22
combined modality therapy (21) 21
diagnosis (19) 19
neuroblastoma - genetics (19) 19
retrospective studies (19) 19
age (17) 17
neoplasm staging (17) 17
neuroblastoma - drug therapy (17) 17
neuroblastoma - mortality (17) 17
neuroblastoma - therapy (17) 17
patients (17) 17
surgery (17) 17
survival rate (17) 17
bone-marrow-transplantation (16) 16
radiotherapy (16) 16
stem-cell transplantation (16) 16
time factors (15) 15
transplantation (15) 15
survival (14) 14
survival analysis (14) 14
young adult (14) 14
childhood (13) 13
clinical trials (13) 13
disease-free survival (13) 13
kaplan-meier estimate (13) 13
life sciences (13) 13
research (13) 13
analysis (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
high-dose chemotherapy (11) 11
high-risk neuroblastoma (11) 11
immunotherapy (11) 11
therapy (11) 11
busulfan (10) 10
busulfan - administration & dosage (10) 10
france (10) 10
gene amplification (10) 10
medulloblastoma (10) 10
metastases (10) 10
randomized-trial (10) 10
brain-tumors (9) 9
cell line, tumor (9) 9
hematopoietic stem cell transplantation (9) 9
induction chemotherapy (9) 9
metastatic neuroblastoma (9) 9
risk-factors (9) 9
stage 4 neuroblastoma (9) 9
vincristine - administration & dosage (9) 9
abstracts (8) 8
antineoplastic agents - adverse effects (8) 8
antineoplastic agents - therapeutic use (8) 8
bone marrow (8) 8
care and treatment (8) 8
childhood-cancer (8) 8
childrens oncology group (8) 8
health aspects (8) 8
metastasis (8) 8
neuroblastoma - diagnosis (8) 8
neuroblastoma - secondary (8) 8
proportional hazards models (8) 8
radiation (8) 8
age factors (7) 7
brain neoplasms - therapy (7) 7
comparative genomic hybridization (7) 7
cyclophosphamide - administration & dosage (7) 7
doxorubicin - administration & dosage (7) 7
epidemiology (7) 7
leukemia (7) 7
long-term survivors (7) 7
mutation (7) 7
mycn (7) 7
neoplasm recurrence, local (7) 7
neuroblastoma - metabolism (7) 7
pediatric oncology (7) 7
pharmacokinetics (7) 7
prospective studies (7) 7
radiation therapy (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bulletin du Cancer, ISSN 0007-4551, 10/2018, Volume 105, Issue 10, pp. 918 - 924
High-risk neuroblastoma comprises nearly half of cases of neuroblastoma and the long-term survival is less than 50% despite complex and intensive treatments.... 
Immunotherapy, Anti-GD2 | High risk neuroblastoma | High dose chemotherapy | Autologous stem cell transplantation
Journal Article
Nature, ISSN 0028-0836, 10/2008, Volume 455, Issue 7215, pp. 967 - 970
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2018, Volume 20, Issue suppl_2, pp. i159 - i159
Abstract BACKGROUND Frontal lobe function is often evaluated with diffuse lesions such as traumatic brain injury, frontal lobe epilepsy. Few cases study has... 
Abstracts
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1074 - 1083
Journal Article
Bulletin du cancer, 10/2018, Volume 105, Issue 10, p. 918
High-risk neuroblastoma comprises nearly half of cases of neuroblastoma and the long-term survival is less than 50% despite complex and intensive treatments.... 
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S68 - S79
New perspectives in immunotherapies for pediatric malignancies: New therapeutic paradigms are needed to improve the survival of children and adolescents with... 
inhibitors | Immune checkpoint | CAR T-cells | Immunotherapy | Monoclonal antibody | Child | Cancer
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2016, Volume 18, Issue suppl 3, pp. iii118.4 - iii119
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 06/2014, Volume 61, Issue 6, pp. 1101 - 1103
We present three pediatric patients with BRAFV600E mutant high‐grade gliomas treated by vemurafenib on a nominative authorization level at our institution. One... 
pharmacokinetics | vemurafenib | anaplastic ganglioglioma | pediatric brain tumors | BRAF mutations | Vemurafenib | Pharmacokinetics | Anaplastic ganglioglioma | Pediatric brain tumors | MELANOMA | ONCOLOGY | METASTASES | PEDIATRICS | BRAF | HEMATOLOGY | Proto-Oncogene Proteins B-raf - physiology | Humans | Male | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Mutation, Missense | Protein Kinase Inhibitors - adverse effects | Bevacizumab | Cancer Vaccines - therapeutic use | Immunotherapy | Fatal Outcome | Camptothecin - administration & dosage | Thalamus | Antineoplastic Agents - pharmacokinetics | Ganglioglioma - surgery | Neoplasm Proteins - genetics | Child | Camptothecin - analogs & derivatives | Protein Kinase Inhibitors - pharmacokinetics | Ganglioglioma - drug therapy | Dacarbazine - administration & dosage | Ganglioglioma - radiotherapy | Combined Modality Therapy | Brain Neoplasms - drug therapy | Sulfonamides - pharmacokinetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Indoles - adverse effects | Indoles - therapeutic use | Neoplasm Proteins - physiology | Drug Evaluation | Salvage Therapy | Infant | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Doxorubicin - analogs & derivatives | Ganglioglioma - enzymology | Astrocytoma - enzymology | Doxorubicin - administration & dosage | Brain Neoplasms - enzymology | Treatment Outcome | Cranial Irradiation | Polyethylene Glycols - administration & dosage | Point Mutation | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Sulfonamides - adverse effects | Indoles - pharmacokinetics | Pediatrics | Children | Gliomas | Health aspects
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 500 - 514
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9823, pp. 1301 - 1309
Journal Article
Nature Medicine, ISSN 1078-8956, 2011, Volume 17, Issue 6, pp. 700 - 707
The natural killer (NK) cell receptor NKp30 is involved in the recognition of tumor and dendritic cells (DCs). Here we describe the influence of three NKp30... 
MEDICINE, RESEARCH & EXPERIMENTAL | NATURAL-KILLER-CELLS | HUMAN DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | IL-10 PRODUCTION | C-KIT | TRIGGERING RECEPTOR | CELL BIOLOGY | NK CELLS | CLASS-III | CYTOTOXICITY RECEPTORS | HUMAN MHC | EXPRESSION | Prognosis | Alternative Splicing - genetics | Humans | Interleukin-12 - physiology | Lysosomal-Associated Membrane Protein 1 - physiology | Interferon-gamma - physiology | Alternative Splicing - physiology | Gastrointestinal Stromal Tumors - physiopathology | Natural Cytotoxicity Triggering Receptor 3 - genetics | Natural Cytotoxicity Triggering Receptor 3 - physiology | Killer Cells, Natural - physiology | Proto-Oncogene Proteins c-kit - physiology | Gastrointestinal Stromal Tumors - diagnosis | Protein Isoforms | Tumor Necrosis Factor-alpha - physiology | Cell Line, Tumor | Polymorphism, Single Nucleotide - genetics | Proto-Oncogene Proteins c-kit - genetics | Gastrointestinal Stromal Tumors - genetics | Dendritic cells | Gastrointestinal tumors | Physiological aspects | Genetic aspects | Research | Gene expression | Interferon | Medical prognosis | Gastrointestinal diseases | Tumors | Cancer | Interferon-gamma | Killer Cells, Natural | Alternative Splicing | Natural Cytotoxicity Triggering Receptor 3 | Interleukin-12 | Proto-Oncogene Proteins c-kit | Tumor Necrosis Factor-alpha | Life Sciences | Lysosomal-Associated Membrane Protein 1 | Immunology | Polymorphism, Single Nucleotide | Gastrointestinal Stromal Tumors
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2016, Volume 18, Issue suppl 3, pp. iii149.1 - iii149
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.